Company intelligence / Profile preview

Environmental Impact Acquisition

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Environmental Impact Acquisition Corp. went public in January 2021 as a SPAC focused on sustainability, healthcare, and life sciences, then merged with GreenLight Biosciences in February 2022, after which the combined entity trades as "GRNA" on Nasdaq[1][4][6]. The SPAC itself had no operations or pipeline prior to the merger[3][5].

Industry: Investors

Beyond the preview

Go deeper on Environmental Impact Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Environmental Impact Acquisition.

Explore the full profile